ArticleCureus2020
Reactive Arthritis in a 37-Year-Old Female With SARS-CoV2 Infection.
Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- COVID-associated arthritis after severe and non-severe COVID-19: A systematic review.Immunity, inflammation and disease · 2023Pooled it
- Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies.Journal of orthopaedic surgery and research · 2023Pooled it
- The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.Journal of autoimmunity · 2021Pooled it
- Reactive arthritis: a comprehensive journey through diagnostic findings.Skeletal radiology · 2025Review
- COVID-19 with Suspected Secondary Pyogenic Arthritis of the Hip: A Case Report and Literature Review.Journal of orthopaedic case reports · 2024Article
- Reactive arthritis following COVID-19: clinical case presentation and literature review.Rheumatology international · 2024Review
- [Clinical relationship between reactive arthritis and SARS-CoV-2 infection: A scoping review].Revista colombiana de reumatologia · 2023Review
- Reactive arthritis following COVID-19: cause for concern.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023Article
- Review
- Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature.Reumatologia clinica · 2023Review
- Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature.Reumatologia clinica · 2023Article
- COVID-19-associated arthritis: an emerging new entity?RMD open · 2022Review
- Review
- Article
- New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.Internal medicine (Tokyo, Japan) · 2022Article
- Reactive arthritis and silent thyroiditis following SARS-CoV-2 infection: Case report and review of the literature.Clinical case reports · 2022Article
- COVID-19-induced psoriatic arthritis: a case report.Therapeutic advances in chronic disease · 2022Article
- Review
- Reactive arthritis after COVID-19: a case-based review.Rheumatology international · 2021Review
- Musculoskeletal involvement of COVID-19: review of imaging.Skeletal radiology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 37-year-old female who presented for evaluation of acute 10/10 right hand pain, 12 days after testing positive for SARS-CoV2. The patient was admitted to the hospital due to the severity of her pain. As an inpatient, extensive workup by the medicine team and rheumatology revealed no structural, vascular, or neurogenic cause of her pain. The patient's blood work was unremarkable for elevations in lyme serology, antinuclear antibody (ANA), rheumatoid factor, and uric acid. It was determined that the cause of her pain was most likely reactive arthritis (ReA) secondary to her SARS-CoV2 infection. She was treated with voltaren gel, neurontin, and oral dilaudid as needed and discharged. Upon follow-up, her pain improved and she was prescribed a wrist splint, ultram, and occupational therapy for perceived wrist tendinitis. To our knowledge, this is the first description of a case of ReA caused by the SARS-CoV2 virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.